File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The PERS Consortium. Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges

TitleThe PERS Consortium. Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges
Authors
Glennon, JPurper-Ouakil, DBakker, MZuddas, AHoekstra, PSchulze, UCastro-Fornieles, JSantosh, PJArango, CKölch, MCoghill, DFlamarique, IPenzol, MJWan, MMurray, MWong, ICKDanckaerts, MBonnot, OFalissard, BMasi, GFegert, JMVicari, SCarucci, SDittmann, RWBuitelaar, JKThe PERS, CONSORTIUM
KeywordsConduct disorder
Pharmacovigilance
Psychopharmacology
Randomised clinical trials
Risperidone
Issue Date2014
Citation
European Child & Adolescent Psychiatry, 2014, v. 23 n. 12, pp 1149-1160 How to Cite?
DOI: http://dx.doi.org/10.1007/s00787-013-0498-3
Persistent Identifierhttp://hdl.handle.net/10722/205958
ISSN
1018-8827
2021 Impact Factor: 5.349
2020 SCImago Journal Rankings: 1.796
ISI Accession Number ID
WOS:000345639200004

 

DC FieldValueLanguage
dc.contributor.authorGlennon, Jen_US
dc.contributor.authorPurper-Ouakil, Den_US
dc.contributor.authorBakker, Men_US
dc.contributor.authorZuddas, Aen_US
dc.contributor.authorHoekstra, Pen_US
dc.contributor.authorSchulze, Uen_US
dc.contributor.authorCastro-Fornieles, Jen_US
dc.contributor.authorSantosh, PJen_US
dc.contributor.authorArango, Cen_US
dc.contributor.authorKölch, Men_US
dc.contributor.authorCoghill, Den_US
dc.contributor.authorFlamarique, Ien_US
dc.contributor.authorPenzol, MJen_US
dc.contributor.authorWan, Men_US
dc.contributor.authorMurray, Men_US
dc.contributor.authorWong, ICKen_US
dc.contributor.authorDanckaerts, Men_US
dc.contributor.authorBonnot, Oen_US
dc.contributor.authorFalissard, Ben_US
dc.contributor.authorMasi, Gen_US
dc.contributor.authorFegert, JMen_US
dc.contributor.authorVicari, Sen_US
dc.contributor.authorCarucci, Sen_US
dc.contributor.authorDittmann, RWen_US
dc.contributor.authorBuitelaar, JKen_US
dc.contributor.authorThe PERS, CONSORTIUMen_US
dc.date.accessioned2014-10-20T10:19:25Z-
dc.date.available2014-10-20T10:19:25Z-
dc.date.issued2014en_US
dc.identifier.citationEuropean Child & Adolescent Psychiatry, 2014, v. 23 n. 12, pp 1149-1160en_US
dc.identifier.issn1018-8827-
dc.identifier.urihttp://hdl.handle.net/10722/205958-
dc.languageengen_US
dc.relation.ispartofEuropean Child & Adolescent Psychiatryen_US
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectConduct disorder-
dc.subjectPharmacovigilance-
dc.subjectPsychopharmacology-
dc.subjectRandomised clinical trials-
dc.subjectRisperidone-
dc.titleThe PERS Consortium. Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challengesen_US
dc.typeArticleen_US
dc.identifier.emailWong, ICK: wongick@hku.hken_US
dc.identifier.authorityWong, ICK=rp01480en_US
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1007/s00787-013-0498-3en_US
dc.identifier.scopuseid_2-s2.0-84912138708-
dc.identifier.hkuros241299en_US
dc.identifier.eissn1435-165X-
dc.identifier.isiWOS:000345639200004-
dc.identifier.issnl1018-8827-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats